First United Bank & Trust Has $750,000 Position in CME Group Inc. (NASDAQ:CME)

First United Bank & Trust lifted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 10.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,400 shares of the financial services provider’s stock after acquiring an additional 315 shares during the period. First United Bank & Trust’s holdings in CME Group were worth $750,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Capital International Investors raised its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. raised its holdings in CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after buying an additional 1,309,097 shares during the last quarter. M&G Plc acquired a new position in CME Group during the first quarter worth $156,631,000. Assenagon Asset Management S.A. raised its holdings in CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after buying an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CME shares. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Barclays increased their target price on shares of CME Group from $209.00 to $219.00 and gave the company an “equal weight” rating in a report on Monday, October 7th. Oppenheimer increased their target price on shares of CME Group from $228.00 to $245.00 and gave the company an “outperform” rating in a report on Monday. JPMorgan Chase & Co. increased their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $219.53.

View Our Latest Report on CME Group

CME Group Trading Up 0.3 %

Shares of CME opened at $224.82 on Wednesday. The company has a market capitalization of $80.95 billion, a P/E ratio of 25.58, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $226.78. The firm’s 50 day simple moving average is $215.60 and its 200 day simple moving average is $208.01. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s revenue was up 12.7% compared to the same quarter last year. During the same period last year, the firm posted $2.30 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.05%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio is 52.33%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.